| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.38 | 3e-33 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-14 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.34 | 3e-12 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.31 | 2e-10 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0002 |